GMED

Over the past six months, Globus Medical's stock price has been impacted by several events. Strong Q3 2025 results led to a significant increase in the stock price. The company reported double-digit sales and earnings growth in its Q4 and Full Year 2025 results. There was an announcement of a board departure. The company added 1 million shares to its equity plan in the 2026 shareholder vote. Robust first-quarter 2026 results, beating expectations and raising full-year guidance, initially caused the stock to trade up, but it later traded down.